Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380185 · ClinicalTrials.gov registry record
Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 1,789
- Enrollment target
NCT00380185: Completed study, sponsored by Stanford University.
NCT00380185 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,789 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380185 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 1,789 participants
- Enrollment target
Study Summary
Atherosclerosis, a condition in which fatty deposits build up along the inner walls of arteries, can occur throughout the body. The purpose of this study is to examine the possible genetic differences that may influence where atherosclerosis occurs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,789 participants |
| Start Date | 2004-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00380185
The ClinicalTrials.gov registry entry for NCT00380185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,789 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00380185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00380185 about?
NCT00380185 is a clinical study titled "Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease". Atherosclerosis, a condition in which fatty deposits build up along the inner walls of arteries, can occur throughout the body. The purpose of this study is to examine the possible genetic differences that may influence where atherosclerosis occurs.
What is the current status of trial NCT00380185?
This trial is currently completed. The enrollment target is 1,789 participants. The study started on 2004-04.
Who is sponsoring clinical trial NCT00380185?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.